Tom Dougherty, CEO – Stealing Share
21 September 2017
American Biopharmaceutical Companies
Go Boldly, the marketing arm of the American Biopharmaceutical Companies, has launched a new TV campaign. It is perfect branding? It just might be.
The key elements in branding
Brand grabs us in the gut. It moves us towards the mystic, to borrow from Van Morrison. I can’t think of a successful brand that has launched with a completely rational message.
All successful brands implant a germ of emotional connection. Such emotional pleas get us to remember and prefer the brand without any hard work.
“Go Boldly is an emotional juggernaut. Destined to change an industry stuck in case studies and platitudes. Well Done. Boldly Gone.”
If you have not seen the commercial look here.
All the key branding elements woven into an unforgettable message. It is smart. Clear. Emotional. Aspirational. And it does not try to speak down to us. It addresses us at eye level. Better said at heart level.
Pharma. An industry under fire
The American Biopharmaceutical Companies are under the gun. Perceptions tie them to runaway healthcare costs. What better way to address the perception than facing it head on?
Driving the heroic theme into our head with the catchy Go Boldly tag is a stroke of genius. But this is even more surprising. (Read about pharmaceutical brand development here.)
Associations rarely do anything right
Nothing infiltrates associations as much as politics. To please all the factions and members most messages turn vanilla. They shy away from being meaningful and direct.
And most are headed by engineers or medical executives. All famously confused by emotional content. Thinking everything is rational. Touting the science and cases studies first. Believing we choose rationally.
Nothing is more incorrect. Research shows us differently. Medical professionals are just like the rest of us.
We make emotional decisions. Then, demonstrating the very definition of rationalization, we fill in the reasons why. The rational stuff. This is the REAL nature of purchase decisions.
The American Biopharmaceutical Companies elevated the argument
I can’t tell you how happy I am to say I was wrong. This group nailed it. They convinced me that its mission is heroic.
Rethink your conceptions. That is the meta message of this campaign. But without lecturing or belittling. I volunteer to come along for the ride.
Can you find a more poignant and effective campaign in your experience? I can’t.
You are wrong.
If you think about it, every campaign that asks you to change your mind is at its root telling you that you are wrong. It is a pivotal moment in brand communication. How do you convince someone of wrongness without offending them?
I’ll tell you how. Follow the lead of The American Biopharmaceutical Companies. I have a new case study. And we all have a new brand and a renewed appreciation of Dylan Thomas. Go boldly.
Disney to buy Fox Tom Dougherty, CEO - Stealing Share 14 December 2017 Disney means business with Fox acquisition What happens when an industry evolves into chaos? You consolidate. Or least that’s what Disney is doing, announcing it’s buying most of 21st Century Fox....
Pizza Inn Express Tom Dougherty, CEO - Stealing Share 13 December 2017 Pizza Inn Express right there with C-store hot dogs Pizza Inn, or rather its parent company Rave, hopes its new concept, Pizza Inn Express, can be a game changer. Pizza Inn Express or PIE (isn’t...
iRig Tom Dougherty, CEO - Stealing Share 12 December 2017 The iRig will steal market share in guitar industry About a year or so ago, Stealing Share wrote a magnum opus on the guitar industry. Okay, maybe it didn’t serve as our Moby Dick moment. But it encompasses the...